Steris (STE) Income from Non-Controlling Interests (2018 - 2026)
Steris' (STE) quarterly Income from Non-Controlling Interests came in at $100000.0 in Q1 2026, down 75.0% year-on-year from $400000.0 in Q1 2025, and down 93.33% quarter-over-quarter from $1.5 million in Q4 2025.
Steris (STE) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
Steris' Income from Non-Controlling Interests history runs 9 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests fell 75.0% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 100.0% increase from a year earlier, with the FY2026 full-year figure at $2.8 million, up 100.0% from the prior year.
- Income from Non-Controlling Interests fell to $100000.0 in Q1 2026 per STE's latest filing, from $1.5 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $1.5 million in Q4 2025 and bottomed at -$507000.0 in Q2 2022.
- The 5-year median for Income from Non-Controlling Interests is $202000.0 (2023), against an average of $269117.6.
- Across the five-year window, Income from Non-Controlling Interests slumped 433.68% in 2022 and surged 1801.85% in 2023, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at -$503000.0 in 2022, then jumped by 140.16% to $202000.0 in 2023, then sank by 199.01% to -$200000.0 in 2024, then surged by 850.0% to $1.5 million in 2025, then tumbled by 93.33% to $100000.0 in 2026.
- Per Business Quant, the three latest STE Income from Non-Controlling Interests figures stand at $100000.0 (Q1 2026), $1.5 million (Q4 2025), and $600000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Steris | 21.56 Bn | 21.12 Bn | 697.10 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | -261,000.00 |
| Dec 31, 2022 | -503,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | -507,000.00 |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | -529,000.00 |
| Sep 30, 2021 | -186,000.00 |
| Jun 30, 2021 | -95,000.00 |